A drug dubbed the “female Viagra” – even though it works differently – has been approved by US regulators the Food and Drug Administration (FDA) despite fears over side effects.<br /><br /> Marketed as “Addyi”, it is the first drug to treat low sexual desire in women.<br /><br /> It will only be available through certified and specially trained health care professionals and pharmacies due to its safety issues.<br /><br /> “Today’s approval provides women distressed by their low sexual desire with an approved treatment option…” Details: http://t.co/ilY06vUOrv— Media Affairs (@FDAMedia) August 18, 2015<br /><br /> The US National Consumers League described the move as the biggest breakthrough in women’s sexual health since the advent of the Pill for contraception.<br /><br /> Also celebrating, the North Carolina company that makes the drug, Sprout Pharmaceuticals, welcomed the decision in a statement.<br /><br /> “All drugs have risks and we want to appropriately inform consumers of risks. So we do have a black box warning. It’s related to low b
